Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 4101 - 4125 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula ▲
Gangliosides LMSP0601ED05
  • NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262776 1629.970562 C79H143N3O31
Gangliosides LMSP0601EF05
  • NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • sialosylparagloboside(d18:1/24:0)
44262792 1629.970562 C79H143N3O31
Gangliosides LMSP0601BY05
  • NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262368 1645.965477 C79H143N3O32
Gangliosides LMSP0601CJ05
  • Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262440 1645.965477 C79H143N3O32
Gangliosides LMSP0601FF05
  • NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262984 1645.965477 C79H143N3O32
Diacylglycerophosphoinositolglycans LMGP15010246
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(16:0/18:0)
126457614 1810.874083 C79H143O43P
Diacylglycerophosphoinositolglycans LMGP15010255
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(18:0/16:0)
126457623 1810.874083 C79H143O43P
Gangliosides LMSP0601DD06
  • KDNalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262585 1616.975313 C79H144N2O31
Gangliosides LMSP0601DF06
  • Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • KDN-GM1(d18:1/26:0)
44262601 1616.975313 C79H144N2O31
Gangliosides LMSP0601EB06
  • KDN-lactotetraosylceramide(d18:1/26:0)
  • KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262761 1616.975313 C79H144N2O31
Gangliosides LMSP0601EC06
  • KDN(2-6)lactotetraosylceramide(d18:1/26:0)
  • KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262769 1616.975313 C79H144N2O31
Gangliosides LMSP0601GE06
  • KDNalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44263169 1616.975313 C79H144N2O31
Gangliosides LMSP0601GG06
  • KDN-(2-6)-neolactotetraosylceramide/sialyl-(2-6)-paragloboside(d18:1/26:0)
  • KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44263185 1616.975313 C79H144N2O31
Diacylglycerophosphoinositolglycans LMGP15010287
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(19:2(9Z,12Z)/16:2(9Z,12Z))
126457655 1816.827133 C80H137O43P
Diacylglycerophosphoinositolglycans LMGP15010281
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(19:1(9Z)/16:2(9Z,12Z))
126457649 1818.842783 C80H139O43P
Diacylglycerophosphoinositolglycans LMGP15010286
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(19:2(9Z,12Z)/16:1(9Z))
126457654 1818.842783 C80H139O43P
Gangliosides LMSP0601CB01
  • KDNalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Neu5Ac)GD1a(d18:1/16:0)
44262388 1767.914232 C80H141N3O39
Gangliosides LMSP0601CC01
  • KDN)GD1a(d18:1/16:0)
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262396 1767.914232 C80H141N3O39
Gangliosides LMSP0601CD01
  • (KDN,Neu5Ac)GD1a 2(d18:1/16:0)
  • KDNalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262404 1767.914232 C80H141N3O39
Diacylglycerophosphoinositolglycans LMGP15010275
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(19:0/16:2(9Z,12Z))
126457643 1820.858433 C80H141O43P
Diacylglycerophosphoinositolglycans LMGP15010280
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(19:1(9Z)/16:1(9Z))
126457648 1820.858433 C80H141O43P
Diacylglycerophosphoinositolglycans LMGP15010285
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(19:2(9Z,12Z)/16:0)
126457653 1820.858433 C80H141O43P
Gangliosides LMSP0601DE02
  • KDNGD1a(d18:1/18:0)
  • KDNalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262589 1754.918983 C80H142N2O39
Gangliosides LMSP0601DI02
  • KDN GD1a 2(d18:1/18:0)
  • KDNalpha2-3Galbeta1-3(KDNalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262621 1754.918983 C80H142N2O39
Gangliosides LMSP0601AN03
  • GD2(d18:1/20:0)
  • GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262070 1702.950556 C80H142N4O34

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024